Arcus Biosciences, Inc. (RCUS) Analyst Forecast

$13.35

south_east
-$0.03 (-0.19%)
Day's range
$13.21
Day's range
$13.58

Recent Analyst Forecasts and Stock Ratings

Date Brokerage Firm Analyst Name Price Target Price when Posted Upside/Downside
on Report Date
Details
10/30/2025 Goldman Sachs Salveen Richter $16.00 $20.64   -22.48%
10/07/2025 Truist Financial Asthika Goonewardene $39.00 $14.48   169.34%
05/07/2025 Wells Fargo Eva Fortea Verdejo $26.00 $8.12   220.2%
10/24/2024 Citigroup Yigal Nochomovitz $46.00 $17.42   164.14%
10/21/2024 H.C. Wainwright Emily Bodnar $20.00 $18.44   8.46%
10/08/2024 Morgan Stanley Judah Frommer $35.00 $18.08   93.58%
10/08/2024 Wells Fargo Eva Fortea Verdejo $29.00 $18.08   60.4%
08/09/2024 Bank of America Securities Jason Zemansky $23.00 $13.69   68.01%
07/08/2024 Barclays Peter Lawson $25.00 $14.00   78.57%
06/24/2024 Truist Financial Asthika Goonewardene $44.00 $16.45   167.48%
06/04/2024 Barclays Peter Lawson $35.00 $16.15   116.72%
05/11/2022 Wedbush Robert Driscoll $42.00 $24.01   74.93%

Arcus Biosciences, Inc. FAQ's

Arcus Biosciences, Inc. has been rated by research analysts at Goldman Sachs, Wedbush, H.C. Wainwright, Truist Financial, Wells Fargo, Citigroup in the past 90 days.